Should Level IIb Be Addressed Routinely in Clinically Node Negative Oral Cancers?

2019 ◽  
pp. 41-49
Author(s):  
Pankaj Chaturvedi ◽  
Akshat Malik
Keyword(s):  
Node Negative ◽  
Oral Cancers

Immunohistochemical (IH) detection of lymph node (LN) micrometastases (MM) dies not predict survival of patient (PT) with node negative esophageal carcinoma (EC)

2001 ◽  
Vol 120 (5) ◽  
pp. A443-A443
Author(s):  
E VAZQUEZSEQUEIROS ◽  
L WANG ◽  
L BURGART ◽  
W HARMSEN ◽  
A ZINSMEISTER ◽  
...  
Keyword(s):  
Lymph Node ◽  
Esophageal Carcinoma ◽  
Node Negative

Lymphatic Mapping and Sentinel Node Identification for Colorectal Cancer

Swiss Surgery ◽  
2001 ◽  
Vol 7 (6) ◽  
pp. 252-255 ◽  
Author(s):  
Ota ◽  
Lin
Keyword(s):  
Sentinel Node ◽  
Lymphatic Mapping ◽  
Primary Treatment ◽  
Stage Iii ◽  
Nodal Disease ◽  
Node Negative ◽  
Intraoperative Procedures ◽  
Sentinel Node Identification ◽  
Node Metastases ◽  
Molecular Assessment

The primary treatment of resectable CRC is surgical resection. Postoperative adjuvant therapies are recommended when lymph node metastases are found (stage III). There is evidence that about 20% of node negative CRC cases (stage II) are understaged, i.e., they are actually node positive (stage III). New intraoperative procedures (lymphatic mapping and sentinel node identification) that are able to detect occult macro- and micrometastases. Molecular assessment of nodal disease should improve the current staging criteria for colon cancer and could influence recommendation for adjuvant treatment.

Oral cancers in India

2001 ◽  
Vol 28 (2) ◽  
pp. 169-173 ◽  
Author(s):  
K. Govind Babu
Keyword(s):  
Oral Cancers
Sign in / Sign up

Export Citation Format

Share Document